Scott D. Kahn

Scott D. Kahn

Director/Board Member at EXAGEN INC.

Net worth: - $ as of 2024-05-30

Health Technology
Technology Services
Consumer Services

Network origin in Scott D. Kahn first degree

EntityEntity typeIndustry
Public Company Medical/Nursing Services 14

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Scott D. Kahn via their personal network

CompanySectorRelated peopleMain position
LIGAND PHARMACEUTICALS INCORPORATED Pharmaceuticals: Major

Tina Nova

Corporate Officer/Principal

AZENTA, INC. Medical/Nursing Services

Tina Nova

Director/Board Member

HESKA CORPORATION Medical Specialties

Tina Nova

Director/Board Member

NGEN INC Medical Specialties

Tina Nova

Founder

ILLUMINA, INC. Biotechnology

Tina Nova

Corporate Officer/Principal

ARENA PHARMACEUTICALS Pharmaceuticals: Major

Tina Nova

Chairman

STAR EQUITY HOLDINGS, INC. Medical Specialties

Kamal Adawi

Corporate Officer/Principal

OPGEN, INC. Miscellaneous Commercial Services

Tina Nova

Director/Board Member

Medical Specialties

Tina Nova

John Aballi

Founder

Corporate Officer/Principal

Miscellaneous Commercial Services

Tina Nova

Director/Board Member

Pharmaceuticals: Major

Tina Nova

Director/Board Member

VERACYTE, INC. Medical Specialties

Tina Nova

John Aballi

Director/Board Member

Corporate Officer/Principal

CASTLE BIOSCIENCES, INC. Medical Specialties

Franklin Stokes

Director of Finance/CFO

GENMARK DIAGNOSTICS, INC. Medical Specialties

Kamal Adawi

Corporate Officer/Principal

Biotechnology

Brian Birk

Ebetuel Pallares

Director/Board Member

Chairman

Michigan State University College/University

Kamal Adawi

Undergraduate Degree

Investment Managers

Bruce Robertson

Private Equity Investor

Investment Banks/Brokers

Franklin Stokes

Corporate Officer/Principal

Investment Managers

Tina Nova

Private Equity Investor

San Diego State University College/University

Kamal Adawi

Graduate Degree

Brandeis University College/University

Ebetuel Pallares

Undergraduate Degree

California Baptist University College/University

John Aballi

Masters Business Admin

Oakland University (Michigan) College/University

Kamal Adawi

Masters Business Admin

University of California, Irvine College/University

Tina Nova

Undergraduate Degree

University of California, Riverside College/University

Tina Nova

Doctorate Degree

University of California San Diego College/University

John Aballi

Undergraduate Degree

The University of North Carolina at Chapel Hill College/University

Franklin Stokes

Graduate Degree

University of San Diego College/University

Tina Nova

Director/Board Member

Miscellaneous Commercial Services

Tina Nova

Chairman

NS WIND DOWN CO., INC. Biotechnology

Tina Nova

Director/Board Member

Investment Managers

Franklin Stokes

Corporate Officer/Principal

Miscellaneous Commercial Services

Tina Nova

John Aballi

Chief Executive Officer

Chief Operating Officer

Pharmaceuticals: Major

Brian Birk

Ebetuel Pallares

Director/Board Member

Director/Board Member

Medical/Nursing Services

Tina Nova

John Aballi

Chief Executive Officer

Corporate Officer/Principal

Miscellaneous Commercial Services

Tina Nova

Chief Executive Officer

Investment Trusts/Mutual Funds

Tina Nova

Director/Board Member

OLINK HOLDING AB Biotechnology

Tina Nova

Director/Board Member

Medical Specialties

Tina Nova

Founder

DMK PHARMACEUTICALS CORPORATION Pharmaceuticals: Major

Tina Nova

Director/Board Member

Miscellaneous Commercial Services

Tina Nova

Director/Board Member

Information Technology Services

Brian Birk

Director/Board Member

Miscellaneous Commercial Services

Kamal Adawi

Director of Finance/CFO

Hospital/Nursing Management

John Aballi

Director/Board Member

Statistics

International

United States 45
Sweden 2
Canada 2

Sectoral

Health Technology 20
Consumer Services 11
Commercial Services 8
Finance 6
Health Services 4

Operational

Director/Board Member 65
Corporate Officer/Principal 50
Independent Dir/Board Member 18
Undergraduate Degree 12
Private Equity Investor 10